Related Experiment Videos
Does surgical stress cause tumor metastasis?
1Kodama Research Institute of Preventive Medicine, Laboratory of Service Section, Nagoya, Japan.
Anticancer Research
|September 1, 1992
Summary
Surgical stress can worsen cancer prognosis by increasing glucocorticoids, which promote tumor metastasis. This study found glucocorticoid excess post-surgery and demonstrated its role in facilitating lung metastasis in mice.
Area of Science:
- Oncology
- Endocrinology
- Cancer Metastasis Research
Background:
- Surgical stress is a potential factor influencing cancer patient prognosis.
- The hypothesis posits that surgical stress elevates glucocorticoid activity, promoting hematogenous tumor metastasis.
Purpose of the Study:
- To investigate the link between surgical stress, glucocorticoid activity, and tumor metastasis.
- To determine if glucocorticoid excess in cervical cancer patients correlates with metastasis.
- To assess the effect of glucocorticoid excess on tumor metastasis in a murine model.
Main Methods:
- Measured glucocorticosteroid levels in cervical cancer patients undergoing radical surgery.
- Utilized a mouse model with inoculated Ehrlich ascites tumor cells to study metastasis.
- Administered hydrocortisone to mice as a proxy for surgical stress-induced glucocorticoid increase.
- Evaluated the efficacy of cyclophosphamide as adjuvant chemotherapy in conditioned mice.
Main Results:
- Glucocorticoid excess was observed in cancer patients during early postoperative recovery.
- Hydrocortisone pretreatment facilitated lung metastasis of tumor cells in mice.
- Glucocorticoids induced lung capillary constriction and tumor cell surface microvillus growth, aiding metastasis.
- Cyclophosphamide demonstrated efficacy in retarding or arresting tumor metastasis in glucocorticoid-conditioned mice.
Conclusions:
- Surgical stress-induced glucocorticoid excess may enhance blood-borne tumor cell metastasis.
- Glucocorticoid actions on capillary lumen and tumor cell morphology contribute to metastasis.
- Adjuvant chemotherapy with cyclophosphamide may counteract postoperative micrometastasis in the context of glucocorticoid activity.